Israel - English - Ministry of Health

novartis israel ltd., israel - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 1 g/vial - ceftazidime - ceftazidime - fortum is indicated for the treatment of the infections listed below in adults and children including neonates (from birth).• nosocomial pneumonia• broncho-pulmonary infections in cystic fibrosis• bacterial meningitis• chronic suppurative otitis media• malignant otitis externa• complicated urinary tract infections• complicated skin and soft tissue infections• complicated intra-abdominal infections• bone and joint infections• peritonitis associated with dialysis in patient on capd.treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (turp).the selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic gram negative bacteria.ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causive bacteria would not fall within its spectrum of activity.consideration should be given to official guidelines on the appropriate use of antibacterial agents.

Malta - English - Medicines Authority

glaxo operations uk limited - ceftazidime - powder for solution for injection - ceftazidime 1 g - antibacterials for systemic use

United Kingdom - English - myHealthbox

glaxo operations uk ltd - ceftazidime - powder for solution for injection or infusion - 2g - anti-bacterials for systemic use. third-generation cephalosporins - it is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). • nosocomial pneumonia • broncho-pulmonary infections in cystic fibrosis • bacterial meningitis • chronic suppurative otitis media • malignant otitis externa • complicated urinary tract infections • complicated skin and soft tissue infections • complicated intra-abdominal infections • bone and joint infections • peritonitis associated with dialysis in patients on capd.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - ceftazidime pentahydrate - powder for solution for injection - 2gram

Canada - English - Health Canada

seagen inc. - enfortumab vedotin - powder for solution - 20mg - enfortumab vedotin 20mg - antineoplastic agents

Canada - English - Health Canada

seagen inc. - enfortumab vedotin - powder for solution - 30mg - enfortumab vedotin 30mg - antineoplastic agents

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline manufacturing s.p.a. - ceftazidime (ceftazidime pentahydrate) - powder for solution for injection/infusion - 1000mg

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - ceftazidime pentahydrate, quantity: 2.328 g (equivalent: ceftazidime, qty 2 g) - injection, powder for - excipient ingredients: sodium carbonate - fortum is indicated for the treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials , but not to ceftazidime, and as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other pseudomonal antibiotics cannot be used. indications include: severe infections in general: for example septicaemia, including neonatal sepsis, bacteraemia, and in patients in intensive care units with specific problems, e.g., infected burns. respiratory tract infections: for example, pneumonia, bronchopneumonia, infected pleurisy, infected bronchiectasis and bronchitis. severe ear, nose and throat infections: for example, otitis media, mastoiditis. urinary tract infections: for example, acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only), and infections associated with bladder and renal stones. skin and soft tissue infections: for example, erys

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - ceftazidime pentahydrate eqv ceftazidime - injection, powder, for solution - 1 g/vial - ceftazidime pentahydrate eqv ceftazidime 1 g/vial

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - ceftazidime pentahydrate eqv ceftazidime - injection, powder, for solution - 2 g/vial - ceftazidime pentahydrate eqv ceftazidime 2 g/vial